Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
Humoral immune response to influenza vaccine in natalizumab-treated MS patients.
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
[Physical rehabilitation in multiple sclerosis: general principles and high-tech approaches].
Is natalizumab overshooting its rebound?
Abrogation of β-Catenin Signaling in Oligodendrocyte Precursor Cells Reduces Glial Scarring and Promotes Axon Regeneration after CNS Injury.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE).
Pregnancy in multiple sclerosis: a questionnaire study.
What to expect after natalizumab cessation in a real-life setting.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
Structure and Activity of the Acid Sensing Ion Channels.
Pages
« first
‹ previous
…
197
198
199
200
201
202
203
204
205
…
next ›
last »